Market revenue in 2022 | USD 2,143.3 million |
Market revenue in 2030 | USD 5,406.3 million |
Growth rate | 12.3% (CAGR from 2022 to 2030) |
Largest segment | Contract manufacturing |
Fastest growing segment | Quality Assurance |
Historical data | 2018 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Quality Assurance, Regulatory Affairs Services, Product Design and Development Services, Product Testing & Sterilization Services, Product Implementation Services, Product Upgrade Services, Product Maintenance Services, Contract Manufacturing |
Key market players worldwide | SGS AG, Labcorp Holdings Inc, Eurofins Scientific SE, Pace Analytical Services, Intertek Group PLC, Wuxi AppTec Co Ltd, Sotera Health Co Ordinary Shares, Charles River Laboratories International Inc, Medical Device Testing Services, FREYR Battery Inc, PAREXEL, Accell, Genpact Ltd, Criterium Inc., Promedica International, Medpace Holdings Inc, Icon PLC, IQVIA Holdings Inc, Integer Holdings Corp, Tecomet, Jabil Inc, Flex Ltd, Celestica Inc Ordinary Shares (Subordinate Voting), Sanmina Corp, Plexus Corp, Molex, Steris PLC, West Pharmaceutical Services Inc, NAMSA, TUV SUD, RJR Consulting, Mandala International, Global Regulatory Partners, Emergo Group, BioTeknica Engineering & Regulatory Services |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to medical device outsourcing market will help companies and investors design strategic landscapes.
Contract manufacturing was the largest segment with a revenue share of 54.74% in 2022. Horizon Databook has segmented the South Korea medical device outsourcing market based on quality assurance, regulatory affairs services, product design and development services, product testing & sterilization services, product implementation services, product upgrade services, product maintenance services, contract manufacturing covering the revenue growth of each sub-segment from 2018 to 2030.
The country has several high-tech manufacturing facilities as well as research infrastructure. The cost of manufacturing and development of medical devices is quite less in the country as compared to developed economies. This is expected to boost the demand for the manufacturing and development of medical devices in South Korea.
South Korea is a prominent destination for clinical trials in Asia, with its superior medical infrastructure and a highly educated, relatively healthy & wealthy population. The government support in the country for developing a robust clinical trial environment is anticipated to contribute to the demand for clinical trial application services, thereby contributing to market growth.
In 2019, the country adopted the Five-year Plan for the Advancement of Clinical Trial to establish the country as a leading clinical trial destination globally. The adoption of such practices in the country by the government is expected to increase clinical studies in the country, thus supporting the market in South Korea.
Horizon Databook provides a detailed overview of country-level data and insights on the South Korea medical device outsourcing market , including forecasts for subscribers. This country databook contains high-level insights into South Korea medical device outsourcing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account